TERT and thyroid gland carcinoma: Thyroid cancer patients with a high probability of harboring TERT promoter mutations can thus be screened for confirmative TERT promoter mutation testing, such as real-time PCR or next-generation sequencing, which can ultimately reduce the medical costs shouldered by them.